Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers L > Headlines for Lexicon Genetics Inc. > News item |
Lexicon reiterated at sector perform by RBC
Lexicon Genetics Inc. was given a sector perform, speculative risk rating by RBC Capital Markets analyst Jason Kantor. According to the analyst, one or more new partnerships over the next three months could catalyze near-term stock appreciation. The advancement of Lexicon's proprietary and partnered drug candidates will likely be the driver for the stock in the longer term. Meaningful clinical data is not expected until later in 2007. Shares of The Woodlands, Texas-based biopharmaceutical company were up $3.69, or 8.40%, at $47.60. (Nasdaq: LEXG)
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.